Some<unk>  have been<unk>  from the market because of risks to the patients. Usually this has been prompted by unexpected adverse effects that were not detected during Phase III clinical trials and were only apparent from post-marketing surveillance data from the wider patient community.
List of withdrawn drugs
List of Schedule III drugs
List of Schedule I drugs
List of Schedule IV drugs
List of Schedule II drugs
List of Schedule V drugs
Drug page template
Risk factor template